KIMS Share Price Falls 2.31% as Krishna Institute of Medical Sciences (KIMS) Declines Today
- September 25, 2026
- Posted by: Harsh Piplani
- Category: News
Krishna Institute of Medical Sciences (KIMS) Share Price fell to Rs 782, down 2.31% today, with market capitalisation at Rs 33,529.12 Cr.
KIMS Share Price moved lower today as Krishna Institute of Medical Sciences traded at Rs 782, down 2.31% from the previous close of Rs 800.50. The company’s market capitalisation stands at Rs 33,529.12 Cr, placing it in the Large Cap category. The move is notable because the supplied data confirms a same-day price fall, but it does not establish a company-specific catalyst. That makes today’s KIMS Share Price action a data-led event rather than a reason-led one. In KIMS Stock News terms, the focus stays on the exact price move, valuation, and sector context that the numbers do support. Investors tracking KIMS Share Price Today can use the session range and fundamentals to frame the decline without drawing unsupported conclusions.
Krishna Institute of Medical Sciences (KIMS) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 782 |
| Previous Close | Rs 800.5 |
| Today's Move | -Rs 18.50 (-2.31%) |
| Open | Rs 805 |
| High | Rs 805 |
| Low | Rs 780.65 |
| Turnover | Rs 0.85 crore |
| Market Capitalisation | Rs 33,529.12 crore |
| Market Cap Category | Large Cap |
KIMS Share Price Today opened at Rs 805, matched the day high of Rs 805, and touched a low of Rs 780.65 before closing at Rs 782. The stock fell Rs 18.50 from the previous close of Rs 800.50, which translates into a 2.31% decline for the session. That is the clearest fact pattern in today’s KIMS Share Price move. The day’s narrow placement between the open and the low shows the stock spent the session near the lower end of the range, while the closing level remained just above the day’s low. Turnover was Rs 0.85 Cr. Because KIMS is a Large Cap company, the day’s move is best read alongside its market capitalisation and valuation rather than through unsupported assumptions. For readers scanning KIMS Stock Falling Today or KIMS Share Price Fall, the verified picture is simply a lower close after an early trade above the opening range.
Krishna Institute of Medical Sciences (KIMS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 33,529.12 crore |
| P/E Ratio | 164.57x |
| P/B Ratio | 8.89x |
| ROE | 11.04% |
| ROCE | 11.51% |
| EPS | Rs 4.86 |
| Book Value Per Share | Rs 90.09 |
| Dividend Yield | 0% |
For investors examining KIMS Fundamental Analysis, the key point is that the stock’s valuation embeds a premium that is visible in the P/E and P/B multiples. That premium needs to be considered alongside the company’s profitability measures, especially when the share price is under pressure on the day. KIMS Financial Results and KIMS Share Price movement should therefore be read together, not separately. The exact ratios do not tell us why the share price fell today, but they do explain why the stock remains in focus for a valuation-based review. In Univest coverage, this is the type of setup where a single-day decline is weighed against hard numbers rather than headlines. The same logic applies to KIMS Latest News and KIMS Company News searches.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 164.57x |
| Benchmark Median P/E | 47.11x |
| Benchmark Average P/E | 100.47x |
| Benchmark P/E Range | 6.89x to 1,570.82x |
| Company P/B Ratio | 8.89x |
| Benchmark Median P/B | 3.88x |
| Benchmark Average P/B | 4.76x |
| Company ROE | 11.04% |
| Benchmark Median ROE | 13.01% |
| Benchmark Average ROE | 13.3% |
| Company ROCE | 11.51% |
| Benchmark Median ROCE | 15.84% |
| Benchmark Average ROCE | 3.15% |
| Company Market Capitalisation | Rs 33,529.12 crore |
| Benchmark Median Market Cap | Rs 544.18 crore |
| Benchmark Average Market Cap | Rs 11,770.59 crore |
The Healthcare sector, specifically the Hospital & Healthcare Services industry, provides the main comparison frame for KIMS Share Price. The benchmark scope covers the same industry and includes 65 companies. Within that set, KIMS trades at a P/E of 164.57 versus the industry median of 47.11 and average of 100.47. On P/B, KIMS stands at 8.89 versus a median of 3.88 and an average of 4.76. ROE at 11.04% sits below the median of 13.01% and average of 13.30%, while ROCE at 11.51% is also below the median of 15.84%. The benchmark market capitalisation median is Rs 544.18 Cr and the average is Rs 11,770.59 Cr, while KIMS Market Cap is Rs 33,529.12 Cr, well above both reference points.
This comparison shows that KIMS Share Price is being assessed in a sector where its valuation multiples sit above the industry central tendency, while its return ratios sit below it. That is useful context for anyone searching KIMS Stock Analysis or KIMS Fundamental Analysis. The company’s market size is materially larger than the industry median, but valuation remains the more prominent feature in the sector comparison. In Univest’s sector view, the exact numbers matter more than broad labels. This is also why KIMS Stock News often sits at the intersection of price action and relative valuation within Healthcare.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,30,272.49 | 61.24 | 13.21 | 23.54 | 21.73 |
| Max Healthcare Institute | MAXHEALTH | 1,02,445.77 | 69.98 | 9.33 | 14.53 | 14.97 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 1,00,021.28 | 109.46 | 5.35 | 12.95 | 13.93 |
| Fortis Healthcare | FORTIS | 67,266.77 | 63.31 | 6.53 | 11.32 | 14.07 |
| Aster DM Healthcare | ASTERDM | 66,295.05 | 210.08 | 15.83 | 13.07 | 16.22 |
KIMS Share Price can be better understood by comparing it with listed healthcare peers in the Hospital & Healthcare Services space. Against Apollo Hospitals Enterprise with a P/E of 61.24, P/B of 13.21, ROE of 23.54% and ROCE of 21.73%, KIMS looks more expensive on earnings but lower on return ratios. Max Healthcare Institute shows a P/E of 69.98 and ROE of 14.53%, again below KIMS on valuation and above it on profitability. Fortis Healthcare trades at a P/E of 63.31 and ROE of 11.32%, placing it below KIMS on earnings multiple and close on return on equity. Aster DM Healthcare has the highest P/E in this peer set at 210.08, while its P/B is 15.83.
Within this peer set, KIMS Share Price sits in a valuation zone that is richer than most peers except Aster DM Healthcare on earnings, but not stronger on ROE or ROCE than Apollo Hospitals. That balance is important for KIMS Share News readers because it shows the stock is not being priced at a discount to the sector. In Univest’s peer lens, the data points to a company that trades at a premium multiple relative to several listed healthcare comparables, while its profitability ratios remain mid-pack rather than leading.
Why Investors Are Watching KIMS
- KIMS Share Price fell 2.31% today to Rs 782.
- The stock closed below the previous close of Rs 800.50 after opening at Rs 805.
- Market capitalisation stands at Rs 33,529.12 Cr, and the stock is classified as Large Cap.
- P/E is 164.57 and P/B is 8.89, both above the industry medians shown in the sector benchmark.
- ROE is 11.04% and ROCE is 11.51%, which are below the sector medians in the supplied benchmark.
About KIMS
Krishna Institute of Medical Sciences operates in the Healthcare sector and the Hospital & Healthcare Services industry. The article’s verified dataset identifies the company within this industry classification and provides market-based metrics used throughout this KIMS Share Price review. For readers searching KIMS Stock News, KIMS Share Price Today or KIMS News Today, the relevant company context here is its sector membership, market capitalisation and valuation profile. Univest uses this same structure to keep company coverage factual, comparable and easy to scan.
Track KIMS Share Price on Univest
Use Krishna Institute of Medical Sciences (KIMS) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Track KIMS Share Price on Univest to follow live price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights in one place. Univest also presents sector comparison and stock analysis tools that help readers place today’s move in a wider context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did KIMS Share Price fall today?
Ans. KIMS Share Price fell 2.31% to Rs 782 on the day, but the supplied data does not establish a company-specific catalyst. The verified numbers only confirm the price event, opening level, close and session range.
What was KIMS Share Price Today?
Ans. KIMS Share Price Today closed at Rs 782 after opening at Rs 805. The previous close was Rs 800.50, so the stock ended Rs 18.50 lower in the session. The stock moved 2.31% lower during the session.
How is KIMS valued compared with healthcare peers?
Ans. KIMS trades at a P/E of 164.57 and P/B of 8.89. Both are above the industry medians in the supplied healthcare benchmark, which puts the stock in a richer valuation band than many peers.
What do KIMS profitability numbers show?
Ans. KIMS reports ROE of 11.04%, ROCE of 11.51%, EPS of Rs 4.86 and book value of Rs 90.09. These figures help frame the share price against earnings and accounting value.
What should readers track next for KIMS Share Price?
Ans. Readers can track future closes, valuation ratios, sector comparison and company financials on Univest. For now, today’s decline, market capitalisation of Rs 33,529.12 Cr and premium valuation are the main verified reference points.
